For instance, it has been shown that the TME of HPV-negative HNSCC compromises higher levels of IL-6 compared to HPV-positive HNSCC and that enhanced IL-6 expression predicts a poor prognosis (96). This evidence concerns the gene IL6 and head and neck squamous cell carcinoma.